Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

3706 results about "Staphylococcus aureus bacteria" patented technology

In medical literature, the bacterium is often referred to as S. aureus, Staph aureus or Staph a.. S. aureus appears as staphylococci (grape-like clusters) when viewed through a microscope, and has large, round, golden-yellow colonies, often with hemolysis, when grown on blood agar plates.

Marine antibacterial peptide and application thereof

The invention relates to the technical field of antibacterial peptides, and particularly discloses a marine antibacterial peptide and application thereof, and the amino acid sequence of the marine antibacterial peptide is as shown in SEQ ID NO.1: MWKLPKWRNGRRRGFKIPRW. The marine antibacterial peptide CD109 provided by the invention has an inhibition effect on staphylococcus aureus, acinetobacter baumannii, pseudomonas aeruginosa and klebsiella pneumoniae, and has extremely low cytotoxicity.
Owner:OCEAN UNIV OF CHINA

Antibacterial peptide or salt thereof, pharmaceutical composition and application

The invention discloses an antibacterial peptide or a salt thereof, a pharmaceutical composition and an application, and belongs to the technical field of biology, the amino acid sequence of the antibacterial peptide is shown as SEQ ID NO: 1, and the antibacterial peptide has a broad-spectrum antibacterial effect and can be used for preparing an antibacterial agent. The compound has a strong bacteriostatic effect on various gram-positive bacteria such as staphylococcus aureus, enterococcus and streptococcus and various gram-negative bacteria such as escherichia coli, acinetobacter baumannii and pseudomonas aeruginosa, and is strong in antibacterial activity, wide in antibacterial spectrum and low in toxicity. The invention also provides a derivative and a salt of the antibacterial peptide and application of the antibacterial peptide, the derivative and the salt of the antibacterial peptide to research, development and preparation of various antibacterial products or / and antibacterial drugs and treatment of bacterial infectious diseases, and the advantages are obvious, and the application prospect is wide.
Owner:SANYA INSTITUTE OF NANJING AGRICULTURAL UNIVERSITY

Barley pest defensin source modified antibacterial peptide and application thereof

The invention discloses a barley pest defensin source modified antibacterial peptide and application thereof. A series of modified antibacterial peptides are designed by adding continuous repetitive sequences of 2-3 pairs of tryptophan or leucine, arginine or lysine at the two ends of the 5th-11th amino acid fragment of barley pest source insect defensin Z-d14CFR, and then the modified antibacterial peptides are synthesized by a solid-phase synthesis method. The modified antibacterial peptide disclosed by the invention has a good bactericidal effect on various gram-negative bacteria and gram-positive bacteria, particularly has an excellent antibacterial effect on methicillin-resistant staphylococcus aureus, and has the characteristics of low cytotoxicity, no hemolysis and the like. The series of modified antibacterial peptides can be self-assembled to form a nanofiber web to adhere bacteria and kill the bacteria in a short time by destroying a bacterial membrane structure, and the modified antibacterial peptides have excellent capability of killing various drug-resistant bacteria clinically and have extremely high application potential in the aspect of clinical application.
Owner:CHINA AGRI UNIV

Antibacterial peptide and antibacterial application thereof

The invention discloses an antibacterial peptide and antibacterial application thereof. The amino acid sequence of the antibacterial peptide is as shown in SEQ ID No.1, and the C end of the antibacterial peptide is amidated. The antibacterial peptide provided by the invention has the activity of resisting staphylococcus aureus and escherichia coli, and plays a role in inhibiting bacteria by destroying cell membranes. The antibacterial peptide is excellent in antibacterial activity, good in stability and not prone to generating drug resistance, can be used for synthesizing and preparing antibacterial compositions, and has great potential in application in the fields of food and medicine.
Owner:JINHUA INSTITUTE OF ZHEJIANG UNIVERSITY

Broad-spectrum antibacterial peptide SS-7 and application thereof

The invention discloses a broad-spectrum antibacterial peptide SS-7 and application thereof, and belongs to the field of biological medicine. The amino acid sequence of the broad-spectrum antibacterial peptide SS-7 disclosed by the invention is VRRVRFVVLRRIKKWRRI, and the broad-spectrum antibacterial peptide SS-7 has a remarkable inhibition effect on various gram-positive bacteria and gram-negative bacteria such as drug-resistant strains such as methicillin-resistant staphylococcus aureus (ATCC43300) and shows low toxicity and no hemolytic toxicity on eukaryotic cells and red blood cells of mammals; lPS and lipoteichoic acid on the surfaces of bacteria can be combined to achieve the effect of neutralizing the bacteria, and a very good treatment and protection effect is achieved on animals infected by the bacteria. The antibacterial peptide SS-7 can be used for preparing an antibacterial agent and preparing a medicine for preventing or treating bacterial infection, has the advantages of being wide in antibacterial spectrum, low in drug-resistant mutation frequency, low in toxicity and low in production cost, can effectively solve the current bacterial drug resistance problem, and has wide application prospects and important clinical value.
Owner:HUAZHONG AGRI UNIV

Bacillus velezensis as well as fermentation product filtrate and biological product thereof

The invention discloses bacillus velezensis as well as fermentation product filtrate and a biological product thereof, and belongs to the technical field of microorganisms, a bacillus velezensis BTN-HB-F4 strain is separated and purified from prinsepia utilis royle in Harba snow mountain in Yunnan province, the fermentation product filtrate of the bacillus velezensis has excellent HAS inhibition capacity and remarkable DPPH and ABTS free radical scavenging capacity, and the biological product of the bacillus velezensis has the advantages that the biological product can be used for preparing biological products of the prinsepia utilis royle; a good anti-oxidation effect can be realized; secondly, under various concentrations, fermentation product filtrate can remarkably reduce the proportion of SA-beta-Gal positive cells, gene expression of matrix metalloproteinase 3 can be remarkably inhibited, and a good anti-aging effect is achieved; in addition, fermentation product filtrate can remarkably inhibit generation of zebra fish melanin and has a good whitening effect; the secretion amount of cell inflammatory factors IL-6 and TNF-alpha can be remarkably inhibited, and a good relieving effect is achieved; finally, the fermentation product filtrate can effectively inhibit the growth of pathogenic bacteria staphylococcus aureus, and has the potential of regulating the skin micro-ecology.
Owner:YUNNAN YUNKE CHARACTERISTIC PLANT EXTRACTION LABORATORY CO LTD +1

Lactobacillus plantarum YM-4-3 and application thereof

The invention discloses a lactobacillus plantarum YM-4-3 which is preserved in the China Center for Type Culture Collection on March 6, 2023, and the preservation number of the lactobacillus plantarum YM-4-3 is CCTCC (China Center for Type Culture Collection) NO: M2023253. The lactobacillus plantarum YM-4-3 disclosed by the invention has the advantages that the lactobacillus plantarum YM-4-3 can effectively improve constipation, has excellent DPPH free radical scavenging rate and ABTS free radical scavenging rate, has good acid resistance, cholate resistance and gastrointestinal tract adhesion capacity, has a very high survival rate in a gastrointestinal tract environment, can remarkably inhibit reproduction of gastrointestinal tract pathogenic bacteria, and can be used for treating constipation. Particularly staphylococcus aureus and salmonella typhimurium salmonella, and can be used for preparing products for preventing or improving constipation and antioxidant products.
Owner:朗恒科技集团有限公司

Murine anti-PBP2a hybridoma cell strain, monoclonal antibody and application

The invention relates to a mouse anti-PBP2a hybridoma cell strain, a monoclonal antibody and application of the mouse anti-PBP2a hybridoma cell strain, staphylococcus aureus PBP2a protein is extracted as an antigen, after the high-purity antigen is obtained, a good immunoreaction is aroused in a mouse body, then a hybridoma technology is adopted, two cell strains with high affinity and specificity are screened, and the corresponding antibody is prepared; the two antibodies are used as a gold-labeled antibody and a coating antibody in a colloidal gold immunoassay kit, and the kit can be used for detecting PBP2a protein in methicillin-resistant staphylococcus aureus and can be used for developing related in-vitro diagnostic reagents.
Owner:TIANJIN ERA BIOLOGY TECH CO LTD +1

Lactobacillus mucilaginosus and application thereof

The invention discloses a lactobacillus mucus fermentation strain and application thereof, and provides a lactobacillus mucus fermentation strain A10 with high yield of exopolysaccharides, and the preservation number of the lactobacillus mucus fermentation strain A10 is CCTCC (China Center for Type Culture Collection) NO: M20242082. The fermented lactobacillus mucus A10 has relatively strong bile salt and gastrointestinal tract digestion tolerance and has an obvious antibacterial effect on escherichia coli and staphylococcus aureus, and the exopolysaccharide synthesized by the fermented lactobacillus mucus A10 is Wzy type exopolysaccharide, is heteropolysaccharide composed of rhamnose, galactose, glucose, mannose and glucuronic acid, and can be used for preparing the exopolysaccharide. The product has good thermal stability and antioxidant activity, and can significantly scavenge free radicals. The lactobacillus mucus A10 extracellular polysaccharide provided by the invention can exert antioxidant activity by activating a Keap1-Nrf2 / ARE signal channel, and is expected to be developed into a natural antioxidant which interacts with Keap1-Nrf2 in a targeting manner.
Owner:YUNNAN AGRICULTURAL UNIVERSITY

Phytobacterium plantarum with bacteriostatic effect and application thereof

The invention discloses a plant lactobacillus with a bacteriostatic effect and application of the plant lactobacillus. The lactobacillus plantarum is named as lactobacillus plantarum C07, the preservation number is CCTCC NO: M20242086, the preservation unit is China Center for Type Culture Collection, the preservation time is September 26, 2024, and the preservation address is Wuhan University, Wuhan University, No. 299, eight road, Wuchang District, Wuhan City, Hubei Province. The strain can produce lactic acid and indole-3-lactic acid at high yield, has a very strong antibacterial effect on multiple putrefying and pathogenic microorganisms such as staphylococcus aureus, escherichia coli, listeria monocytogenes, pseudomonas aeruginosa, salmonella and mould, and is a broad-spectrum antibacterial microorganism.
Owner:YUNNAN AGRICULTURAL UNIVERSITY

Antibacterial ceramic and preparation method thereof

The invention provides antibacterial ceramic and a preparation method thereof. The antibacterial ceramic comprises a blank body and a glaze layer, the blank body is prepared from the following raw materials: kaolin, diatomite, montmorillonite, soapstone, bamboo charcoal powder, a first antibacterial agent, a fluxing agent, a pore forming agent, an adhesive and a reinforcing agent; the glaze layer comprises the following raw materials: kaolin, diatomite, dolomite, tourmaline, sodium oxide, a second antibacterial agent, a binder, a stabilizer and a dispersant. The method comprises the following steps: firing a molded green body by adopting stepped segmented heating, and carrying out glaze firing by adopting stepped segmented heating after glazing, thereby obtaining the antibacterial ceramic. According to the antibacterial ceramic disclosed by the invention, the antibacterial agent is added into the green body and the glaze layer, so that the influence on the antibacterial property of the green body in the firing process of the green body is avoided, the antibacterial durability is further improved, the antibacterial effect is enhanced, and the antibacterial rate on pathogenic bacteria such as escherichia coli and staphylococcus aureus reaches 99.99%.
Owner:DEHUAQIAO CRAFTSMAN CERAMIC TECH CO LTD

Polyrotaxane covalent organic framework material for regulating interlayer spacing through cyclodextrin and application of polyrotaxane covalent organic framework material

The invention discloses a polyrotaxane covalent organic framework material capable of regulating interlayer spacing through cyclodextrin and application of the polyrotaxane covalent organic framework material, and belongs to the technical field of biological medicine. The polyrotaalkylated covalent organic framework material is obtained by taking a cyclodextrin aromatic multi-amino inclusion compound and a (multi-aldehyde bipyridine) ruthenium (II) complex as structural units and carrying out copolymerization; the cyclodextrin aromatic polyamine inclusion compound is a beta-cyclodextrin p-phenylenediamine inclusion compound with a hydroxyl group or without a hydroxyl group; the (multi-aldehyde dipyridyl) ruthenium (II) complex is tris (4, 4 '-diformaldehyde-2, 2'-dipyridyl) ruthenium (II). The interlayer spacing of the polyrotaxane covalent organic framework material is greatly increased by utilizing a cavity of gamma-cyclodextrin, and meanwhile, the material has excellent photo-thermal and photodynamic activity, is positively charged, and can better adsorb negatively charged bacteria; and the hydrogel is good in biocompatibility and free of toxic and side effects, and has an excellent treatment effect on wounds infected with staphylococcus aureus.
Owner:WEIFANG MEDICAL UNIV

High-performance photocatalytic metal organic framework antibacterial material as well as preparation method and application thereof

The invention belongs to the technical field of metal organic frameworks, and particularly relates to a high-performance photocatalytic metal organic framework antibacterial material as well as a preparation method and application thereof. The preparation method comprises the following steps of: growing a metal organic framework UiO 66 which takes a cerium element as a metal node on a single-layer graphene oxide UiO66 (at) GO in situ, loading arginine small molecules in the MOF framework to obtain a high-performance photocatalytic MOF antibacterial material UiO66 (at) GO (at) arg, forming a nano hydrogel with a stable three-dimensional structure with chitosan, and performing antibacterial treatment by using the nano hydrogel as a wound dressing. The Ce-based MOF composite QCS / GO-UiO 66-coated arg / PNIPAm hydrogel prepared by the preparation method disclosed by the invention has excellent properties such as elasticity, adhesive power, water absorption and biocompatibility; and under illumination, the photocatalyst has an excellent photocatalytic sterilization effect, and has a good killing effect on escherichia coli and staphylococcus aureus.
Owner:GUANGZHOU MEDICAL UNIV

Lactobacillus plantarum with antibacterial effect and application thereof

The invention relates to the field of microorganisms, and discloses lactobacillus plantarum with an antibacterial effect and application of the lactobacillus plantarum, and the preservation number of the lactobacillus plantarum is CGMCC (China General Microbiological Culture Collection Center) No.33151. The strain provided by the invention has relatively strong cholate resistance, gastric acid resistance, acid production and H2O2 production capabilities, and has a relatively strong bacteriostatic effect on common pathogenic bacteria such as staphylococcus aureus, candida albicans, escherichia coli, salmonella and helicobacter pylori; the compound can inhibit the activity of urease, interfere helicobacter pylori colonization and the like to inhibit helicobacter pylori infection or reduce the symptoms of helicobacter pylori infection and reduce the disease degree of mice with colitis, can be used for preparing microbial preparations, and has the potential of preparing drugs for preventing and / or treating diseases caused by helicobacter pylori infection.
Owner:COFCO NUTRITION AND HEALTH RESEARCH INSTITUTE CO LTD +1

Plant lactobacillus with efficient broad-spectrum bacteriostatic activity

The invention relates to the field of microorganisms, in particular to a plant lactobacillus and application thereof in bacteriostasis. Specifically, the preservation number of the plant lactobacillus LP06 is CGMCC (China General Microbiological Culture Collection Center) No. 28412. The plant lactobacillus LP06 provided by the invention can be used for inhibiting the growth of debaryomyces hansenii, candida tropicalis and penicillium rochei, and also has an inhibiting effect on super bacteria acinetobacter baumannii, pseudomonas aeruginosa, klebsiella, escherichia coli, staphylococcus aureus and listeria monocytogenes. The plant lactobacillus LP06 provided by the invention has broad-spectrum bacteriostatic ability, and bacteriostatic powder prepared from the bacterium can be used as a biological preservative for corrosion prevention of dairy products such as yoghourt, cheese and the like and other foods.
Owner:INNER MONGOLIA YILI IND GROUP CO LTD +2

Lactobacillus paracasei, probiotic preparation beneficial for improving immunity and preparation method of probiotic preparation

The invention provides a Lactobacillus paracasei, which has a preservation number of CGMCC (China General Microbiological Culture Collection Center) No.32951. The Lactobacillus paracasei has a preservation number of CGMCC No.32951. The Lactobacillus paracasei has a preservation number of CGMCC No.32951. The lactobacillus paracasei ID001 provided by the invention has an inhibition effect on enteropathogenic bacteria such as salmonella, escherichia coli, staphylococcus aureus and the like. The probiotic preparation is obtained through fermentation and the dendrobium officinale extract, and the probiotic preparation has the immunoregulation effect through performance verification and screening.
Owner:HUNAN NUTRITION TREE BIOTECHNOLOGY CO LTD

Extract based on roselle oil and roselle polypeptide as well as extraction method and application of extract

The invention relates to the related technical field of extraction of active ingredients in roselle calyx, and particularly provides an extract based on roselle oil and roselle polypeptide as well as an extraction method and application of the extract. The extraction method comprises the following steps: S1, sequentially performing crushing treatment and supercritical fluid extraction treatment on roselle calyx to obtain a roselle oil extract and flower residues; s2, the roselle residues are sequentially subjected to fermentation treatment and enzymolysis treatment, and a roselle polypeptide extract is obtained; wherein a strain used in the fermentation treatment is selected from at least one of saccharomyces cerevisiae, bacillus subtilis and lipomyces starkeyi; an enzyme used in the enzymolysis treatment is selected from at least one of acid protease and compound protease; the extract comprises the roselle oil extract and the roselle polypeptide extract. The extraction method provided by the invention improves the extraction rate of active ingredients extracted from roselle calyx.
Owner:BEIJING TECH & BUSINESS UNIV

Antibacterial peptide cAMP048 and application thereof

The invention provides an antibacterial peptide cAMP048 sourced from microorganisms in a deep sea environment and application of the antibacterial peptide cAMP048, and belongs to the technical field of peptide inhibitors. The antibacterial peptide cAMP048 has an amino acid sequence as shown in SEQ ID NO: 1 (Sequence Identity Number 1). The antibacterial peptide can inhibit the growth of acinetobacter baumannii at 64 mu M, inhibit the growth of multi-drug-resistant acinetobacter baumannii and multi-drug-resistant enterococcus faecium at 128 mu M and inhibit the growth of escherichia coli, staphylococcus aureus and multi-drug-resistant klebsiella pneumoniae at 256 mu M. The antibacterial peptide can be used for preparing products with antibacterial and / or bactericidal performance, and can be applied to preparation of antibacterial and / or bactericidal products. Such as food, skin care products or medical supplies.
Owner:BGI RESEARCH SANYA

Composite hydrogel dressing for promoting wound healing, preparation and application

The invention relates to a composite hydrogel dressing for promoting wound healing as well as preparation and application thereof, and belongs to the technical field of biological medicines. The hydrogel disclosed by the invention is prepared by mixing gelatin, oxidized dextran and metal ion modified metal-organic framework compounds (MOF-Ag and MOF-Cu). In the mixed solution, amino groups in the gelatin and aldehyde groups of the oxidized dextran are subjected to a Schiff base cross-linking reaction, and the composite hydrogel is formed after standing. The loaded MOF-Ag has antibacterial and anti-biofilm effects on staphylococcus aureus and escherichia coli, and the loaded MOF-Cu has similar superoxide dismutase activity and similar glutathione peroxidase activity, so that excessive active oxygen can be removed, and inflammatory response can be relieved. The obtained hydrogel has good biocompatibility, proper mechanical properties and biological adhesion, stable rheological properties, excellent antibacterial and anti-inflammatory functions and a certain hemostatic function.
Owner:HUAZHONG UNIV OF SCI & TECH

Pleuromutilin derivative as well as preparation method and application thereof

The invention belongs to the technical field of antibacterial drugs, and discloses a pleuromutilin derivative and a preparation method and application thereof.The pleuromutilin derivative is a compound with the structure shown in the formula I and pharmaceutically acceptable salt of the compound, and in the formula, R1, R2 and R3 are H, OMe, NO2, Me, F, Cl or Br. According to the present invention, the structure is novel, the antibacterial activity is excellent, and the in vitro antibacterial experiment result shows that the antibacterial activity of more than 90% of the compound on the Gram-positive bacteria staphylococcus aureus drug-resistant strains ATCC 33591 and ATCC 43300 and the staphylococcus aureus sensitive strain ATCC 2913 is superior to the antibacterial activity of tiamulin, such that the tiamulin is expected to be used in the treatment of the bacterial infection caused by the staphylococcus aureus, and the application prospect is broad. And a new choice is provided for anti-infection drugs.
Owner:XIHUA UNIV

Coumarin thioether pleuromutilin derivative and application thereof

The invention belongs to the technical field of antibacterial drugs, and discloses a coumarin thioether pleuromutilin derivative and application thereof.The coumarin thioether pleuromutilin derivative is a compound with the structure shown in the formula I and pharmaceutically acceptable salt of the compound, and in the formula, R1 and R2 are H, OMe, NO2, NH2, Me, F, Cl or Br. The antibacterial agent is novel in structure and has excellent antibacterial activity. In-vitro antibacterial experiment results show that all the compounds have antibacterial effects superior to that of tiamulin, most of the compounds have antibacterial effects equivalent to that of control valnemulin, and the compound has a significant effect on five gram-positive bacteria staphylococcus aureus drug-resistant strains ATCC 33591 and ATCC 43300, staphylococcus aureus sensitive strains ATCC 2913, staphylococcus epidermidis drug-resistant strains ATCC 51625, staphylococcus epidermidis sensitive strains ATCC 12228, staphylococcus aureus drug-resistant strains ATCC 51625, staphylococcus aureus sensitive strains ATCC 12228, staphylococcus aureus drug-resistant strains ATCC 51625 and staphylococcus aureus sensitive strains ATCC 12228. Wherein the bacteriostatic activities of the nine compounds are less than or equal to 0.062 mu g.mL <-1 >. The compound is expected to be applied to treatment of bacterial infection caused by staphylococcus aureus, and a new choice is provided for anti-infection drugs.
Owner:XIHUA UNIV

Lactobacillus plantarum and application thereof in preparation of medicine for preventing and / or treating vaginitis

The invention relates to the field of microorganisms, and discloses lactobacillus plantarum and application of the lactobacillus plantarum in preparation of a medicine for preventing and / or treating vaginitis, and the preservation number of the lactobacillus plantarum is CGMCC No.33152. The lactobacillus plantarum provided by the invention has a relatively strong bacteriostatic effect on common vaginal pathogenic bacteria such as Atortoria, staphylococcus aureus, Candida albicans, Escherichia coli and Gardneria, and also can reduce the infection degree of the pathogenic bacteria by inhibiting colonization and reproduction of the pathogenic bacteria; in addition, the proinflammatory factor level in sick vaginitis tissues is reduced, and the anti-inflammatory factor level is improved.
Owner:COFCO NUTRITION AND HEALTH RESEARCH INSTITUTE CO LTD +1

Inflammation-targeting bionic extracellular vesicle as well as preparation method and application thereof

The invention discloses an inflammation-targeting bionic extracellular vesicle as well as a preparation method and application thereof, and particularly relates to the field of medicines. According to the invention, a new generation of aminoglycoside antibiotic teicoplanin (Teic), which is high in albumin binding rate and weak in intracellular antibacterial effect, is loaded on neutrophil-derived extracellular vesicles (NEV) with natural drug carrying capacity and inflammatory response chemotactic capacity to prepare the drug-loaded vesicles (Teic-NEV), wherein the new generation of aminoglycoside antibiotic teicoplanin (Teic) is used for loading the neutrophil-derived extracellular vesicles (NEV). The drug-loaded extracellular vesicle Teic-NEV can be used for targeted therapy of cells and tissues infected by MRSA (Methicillin-Resistant Staphylococcus Aureus). In vitro, the Teic (at) NEV can be used for destroying MRSA mature biological membranes and killing intracellular MRSA. According to the invention, the in-vivo and in-vitro biological safety of the TeicatNEV is evaluated. Therefore, the invention provides a certain theoretical basis for the application of NEV-based drug delivery in the field of intracellular bacteria treatment, and also provides a new treatment strategy for in-vivo targeted treatment.
Owner:ZHEJIANG UNIV

Epoxy group modified zwitterionic polymer / heparin composite coating and preparation method thereof

The invention discloses an epoxy group modified zwitterionic polymer / heparin composite coating and a preparation method thereof. The preparation method comprises the following steps: firstly, constructing an amino-containing adhesion layer on the surface of a substrate by adopting a dip-coating method; then, the substrate is soaked in a mixed solution of the zwitterionic polymer and the heparin, and grafting of the zwitterionic polymer and the heparin on the surface of the medical material is completed through incubation. The coating provided by the invention has excellent hydrophilicity, can form a hydration layer, provides a physical barrier, and remarkably prevents adhesion and colonization of microorganisms. The inhibition rate of the coating on escherichia coli and staphylococcus aureus exceeds 99%, protein adhesion is remarkably reduced in an anti-protein adhesion experiment, and the coating is simple in strategy design, has a potential application prospect in the aspect of preventing blood contact catheter related infection and thrombosis, and has a wide application prospect. The complication occurrence rate and the medical care cost can be reduced.
Owner:SHAANXI UNIV OF SCI & TECH

Lactobacillus gasseri FMTA1125B with effect of preventing, relieving or treating vaginitis and application of lactobacillus gasseri FMTA1125B

The invention relates to lactobacillus gasseri FMTA1125B with the effect of preventing, relieving or treating vaginitis and application of the lactobacillus gasseri FMTA1125B. The lactobacillus gasseri FMTA1125B is classified and named as lactobacillus gasseri, and the preservation number of the lactobacillus gasseri FMTA1125B is CGMCC No.34292. The lactobacillus gasseri FMTA1125B has the effects of preventing, relieving or treating vaginitis and the application of the lactobacillus gasseri FMTA1125B. The bacterium can produce beneficial components such as lactic acid, gamma-aminobutyric acid and hydrogen peroxide through metabolism so as to regulate the genital tract environment and improve the health degree; and the traditional Chinese medicine composition has relatively good bacteriostasis and sterilization effects on common vaginal pathogenic bacteria such as escherichia coli, staphylococcus aureus, gardnerella vaginalis, candida albicans, neisseria gonorrhoeae and the like. Therefore, the lactobacillus gasseri FMTA1125B strain can be used for preparing a preparation with the effect of improving related genital tract diseases such as vaginitis.
Owner:BEIJING FUMART BIOTECHNOLOGY CO LTD

Antibacterial peptide with broad-spectrum antibacterial effect, antibacterial product and application

The invention belongs to the field of antibacterial peptides, and particularly relates to an antibacterial peptide with a broad-spectrum antibacterial effect, an antibacterial product and application. The antibacterial peptide is named as CAMP1111NC, and is obtained by performing N-terminal acetyl end capping and C-terminal amino end capping on polypeptide shown in SEQ ID NO: 1. The antibacterial peptide has remarkable antibacterial activity on a staphylococcus aureus standard strain ATCC12600, pseudomonas aeruginosa PAO1, klebsiella pneumoniae, an acinetobacter baumannii standard strain ATCC19606, methicillin-resistant staphylococcus aureus ATCC33591, methicillin-resistant and gentamicin-resistant staphylococcus aureus ATCC33592 and acinetobacter baumannii bio-53272 resistant to various antibiotics, and the antibacterial peptide can be used for preparing the antibacterial peptide. The limitation of the traditional antibacterial peptide is effectively overcome.
Owner:OCEAN UNIV OF CHINA

Lactococcus gasseri C6a2 and application thereof

The invention discloses lactococcus gasseri C6a2 and application thereof. The preservation number of the lactococcus gasseri C6a2 is CGMCC (China General Microbiological Culture Collection Center) NO: 31024; the 16S rRNA (ribosomal Ribonucleic Acid) gene sequence of the lactococcus gasseri C6a2 is as shown in SEQ ID NO: 1. The bacterial strain is a macrobrachium rosenbergii intestinal absolute dominant bacterium, has a typical probiotic function, is high in growth speed and activity, can quickly enter a logarithmic phase, has relatively high acid production and acid resistance, can secrete lipase, has relatively high bacteriostatic activity on staphylococcus aureus, aeromonas hydrophila and aeromonas veronii, and can be used for preparing the macrobrachium rosenbergii. The bacterium can be used for preparing a special probiotic preparation for macrobrachium rosenbergii, so that the sustainable development of the macrobrachium rosenbergii industry in China is promoted.
Owner:HUZHOU UNIVERSITY +1

Antibacterial peptide for inhibiting drug-resistant staphylococcus aureus and application thereof

The invention relates to the technical field of antibacterial peptide application, in particular to an antibacterial peptide for inhibiting drug-resistant staphylococcus aureus and application of the antibacterial peptide. The antibacterial peptide is obtained by performing N-terminal acetylation modification and C-terminal amidation modification on polypeptide as shown in SEQ ID NO.1. The invention further discloses a preparation method of the antibacterial peptide. The antibacterial peptide provided by the invention is a novel cationic antibacterial peptide, the minimum inhibitory concentrations of the antibacterial peptide to pathogenic bacteria staphylococcus aureus ATCC12600 and staphylococcus aureus ATCC33591 are respectively 4 [mu] g / mL and 32 [mu] g / mL, the biological safety is extremely high, and due to the characteristics, the antibacterial peptide shows extremely high medical drug antibacterial value, and can be used for preparing the antibacterial peptide. Alternative medicinal resources are provided for clinically resisting the two human pathogenic bacteria in the future.
Owner:OCEAN UNIV OF CHINA

Lactobacillus crispatus and use thereof

The invention provides lactobacillus crispatus, which is preserved in the general microbiological center of the China Committee for Culture Collection of Microorganisms on February 7, 2023, and the preservation number is CGMCC (China General Microbiological Culture Collection Center) No. 26503. The bacillus subtilis can play a relatively strong role in inhibiting pathogenic bacteria such as gardnerella vaginalis, escherichia coli and staphylococcus aureus at the same time, and also has a certain role in inhibiting candida albicans, two-way proteurella and Atortoria vaginalis. Therefore, the lactobacillus crispatus has the potential of maintaining the environment in the vagina to be faintly acid and improving the mucosal immunity and infection resistance of a host, and can be used for preventing and treating vaginal infection and inflammation, and maintaining, improving or recovering the steady state of the environment in the vagina.
Owner:HANGZHOU GRAND BIOLOGIC PHARMA INC

Nucleic acid composition for respiratory tract pathogen detection and application thereof

The invention provides a nucleic acid composition for respiratory tract pathogen detection and application thereof, and relates to the technical field of biology. The invention provides a nucleic acid detection composition which has high specificity and can be used for detecting various respiratory pathogens. The composition can be used for detecting influenza B virus, influenza A virus H1N1, influenza A virus H3N2, novel coronavirus N gene, novel coronavirus O gene, respiratory syncytial virus, I-type parainfluenza virus, II-type parainfluenza virus, III-type parainfluenza virus, IV-type parainfluenza virus, rhinovirus, adenovirus, haemophilus influenzae, and the like. The kit has 15 pathogens including streptococcus pneumoniae and staphylococcus aureus, the lower detection limit can be as low as 20 copies / reaction, and the kit plays an important role in rapid detection of respiratory tract pathogens.
Owner:ZHUHAI LIVZON DIAGNOSTICS